DDInter1271 DDInter278
Nebivolol is a racemic mixture of 2 enantiomers where one is a beta adrenergic antagonist and the other acts as a cardiac stimulant without beta adrenergic activity. Treatment with nebivolol leads to a greater decrease in systolic and diastolic blood pressure than [atenolol], [propranolol], or [pindolol]. Nebivolol and other beta blockers are generally not first line therapies as many patients are first treated with thiazide diuretics. Nebivolol was granted FDA approval on 17 December 2007.
Calcium lactate is a salt that consists of two lactate anions for each calcium cation (Ca2+). It is prepared commercially by the neutralization of lactic acid with calcium carbonate or calcium hydroxide. Approved by the FDA as a direct food substance affirmed as generally recognized as safe, calcium lactate is used as a firming agent, flavoring agent, leavening agent, stabilizer, and thickener . Calcium lactate is also found in daily dietary supplements as a source of calcium. It is also available in various hydrate forms, where calcium lactate pentahydrate is the most common.
Nebivolol {u} (Compound) treats {v} (Disease) hypertension
Nebivolol {u} (Compound) binds {v} (Gene) ADRB2
Nebivolol {u} (Compound) causes {v} (Side Effect) Headache
Nebivolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magnesium oxide
Nebivolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magnesium carbonate
Nebivolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Physostigmine
Nebivolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Empagliflozin
Nebivolol {u} may lead to a major life threatening interaction when taken with {v} Fingolimod
Nebivolol {u} may lead to a major life threatening interaction when taken with {v} Dyphylline
Nebivolol (Compound) treats hypertension (Disease)
Nebivolol (Compound) binds ADRB2 (Gene)
Nebivolol (Compound) causes Headache (Side Effect)
Nebivolol may cause a minor interaction that can limit clinical effects when taken with Magnesium oxide
Nebivolol may cause a minor interaction that can limit clinical effects when taken with Magnesium carbonate
Nebivolol may cause a moderate interaction that could exacerbate diseases when taken with Physostigmine
Nebivolol may cause a moderate interaction that could exacerbate diseases when taken with Empagliflozin
Nebivolol may lead to a major life threatening interaction when taken with Fingolimod
Nebivolol may lead to a major life threatening interaction when taken with Dyphylline